Regulatory Milestone Payments. In consideration of the rights, privileges, and licenses granted herein, LPT shall pay to AERES in United States Dollars (US Dollars) each of the following regulatory milestone payments in respect of each Designated Antibody (“Regulatory Milestone Payments”): (i) AERES will receive either: (a) [*** ] of LPT’s negotiated Regulatory Milestone Payment (if any) receivable from a development partner or Licensee, on first filing of a US IND or equivalent in any country; or [*** ] US Dollars [*** ]; or:
Appears in 2 contracts
Sources: Research Collaboration Agreement, Research Collaboration Agreement (Lpath Inc)